Case ReportBrain
Ipilimumab-Induced Hypophysitis: MR Imaging Findings
K.J. Carpenter, R.D. Murtagh, H. Lilienfeld, J. Weber and F.R. Murtagh
American Journal of Neuroradiology October 2009, 30 (9) 1751-1753; DOI: https://doi.org/10.3174/ajnr.A1623
K.J. Carpenter
R.D. Murtagh
H. Lilienfeld
J. Weber

References
- 1.↵
- 2.↵
- Weber J
- 3.↵
- Cranmer LD,
- Hersh E
- 4.↵
- Cheung CC,
- Ezzat S,
- Smyth HS,
- et al
- 5.↵
- Sautner D,
- Saeger W,
- Ludecke DK,
- et al
- 6.↵
- Swearingen B,
- Biller BM
- 7.↵
- Ahmadi J,
- Meyers GS,
- Segall HD,
- et al
- 8.↵
- Sato N,
- Sze G,
- Endo K
- 9.↵
- Sato N,
- Ishizaka H,
- Yagi H,
- et al
- 10.↵
- Maghnie M,
- Genovese E,
- Arico M,
- et al
In this issue
Advertisement
Ipilimumab-Induced Hypophysitis: MR Imaging Findings
K.J. Carpenter, R.D. Murtagh, H. Lilienfeld, J. Weber, F.R. Murtagh
American Journal of Neuroradiology Oct 2009, 30 (9) 1751-1753; DOI: 10.3174/ajnr.A1623
Jump to section
Related Articles
- No related articles found.
Cited By...
- MRI Findings of Immune Checkpoint Inhibitor-Induced Hypophysitis: Possible Association with Fibrosis
- Adrenal Insufficiency Related to Anti-Programmed Death-1 Therapy
- Ipilimumab Therapy for Melanoma: A Mimic of Leptomeningeal Metastases
- Long-term follow-up of ipilimumab-induced hypophysitis, a common adverse event of the anti-CTLA-4 antibody in melanoma
- ENDOCRINE SIDE-EFFECTS OF ANTI-CANCER DRUGS: mAbs and pituitary dysfunction: clinical evidence and pathogenic hypotheses
- Neurological immune-related adverse events of ipilimumab
- Ipilimumab and Its Toxicities: A Multidisciplinary Approach
- MECHANISMS IN ENDOCRINOLOGY: Ipilimumab: a novel immunomodulating therapy causing autoimmune hypophysitis: a case report and review
This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.
More in this TOC Section
Similar Articles
Advertisement